Ethylene

Ethylene

SCHEMBL6997843

C=C.CCOC(C)OCC.COc1cccc2c1C(=O)CN(CCCN1CCN(c3ccccc3F)CC1)S2(=O)=O

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 9/20 0.44
DRD3 P35462 4/20 0.44
DRD4 P21917 2/20 0.44
DRD5 P21918 1/20 0.44
HTR7 P34969 8/20 0.43
HTR1A P08908 5/20 0.43
HTR2A P28223 5/20 0.43
HTR6 P50406 5/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL6995181 0.89 DRD2 (0.43) DRD2DRD3DRD4DRD5HTR7
Ethylene SCHEMBL6995689 0.89 HTR7 (0.41) DRD2DRD3DRD4DRD5HTR7
Ethylene SCHEMBL6997038 0.88 HTR7 (0.42) DRD2DRD3DRD4DRD5HTR7
Ethylene SCHEMBL7001820 0.87 DRD2 (0.53) DRD2DRD3DRD4DRD5HTR7
Ethylene SCHEMBL6992834 0.86 DRD2 (0.39) DRD2DRD3DRD4DRD5HTR7
Ethylene SCHEMBL6992328 0.85 HTR1A (0.46) DRD2DRD3DRD4HTR7HTR1A
Ethylene SCHEMBL6994102 0.85 HTR1A (0.48) DRD2DRD3DRD4HTR7HTR1A
Ethylene SCHEMBL6995582 0.84 MEN1 (0.40) DRD2DRD3DRD4HTR7HTR1A
Ethylene SCHEMBL6992896 0.81 CYP2D6 (0.44) DRD2HTR2AMEN1KMT2ACYP1A2
Ethylene SCHEMBL6993539 0.81 TDP1 (0.35) DRD2DRD3DRD4DRD5HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664251-B2 Serotonin receptor antagonist; treating cardiovascular disorder DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2003-12-16 US disclosed
US-20030078256-A1 Benzothiazine derivative SUNTORY LIMITED (JP) 2003-04-24 US disclosed
EP-0749967-B1 Substituted benzothiazine derivative SUNTORY LTD (JP) 2003-01-22 EP disclosed
US-6316442-B1 TREATMENT OF HEART DISEASE AND CEREBROVASCULAR DISTURBANCES SUNTORY LIMITED (JP) 2001-11-13 US disclosed
US-6001827-A Benzothiazine derivative SUNTORY LIMITED (JP) 1999-12-14 US disclosed
EP-0749967-A1 Substituted benzothiazine derivative SUNTORY LIMITED (JP) 1996-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078256-A1 Benzothiazine derivative TPH2, ADRB2, TPH1 DRD2 402/4885DRD3 341/4885DRD4 648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.